Some studies reported that MALAT1 inhibited E-cadherin expression by binding to highly expressed EZH2 at its 3′ end in colorectal cancer, thereby caused tumor cell epithelial-mesenchymal transition (EMT) and oxaliplatin resistance [27]. Here, EZH2 is linked to neoplasm.